Fig 1.
(A) Overall survival for E1694 patients (n = 670) with baseline S100B level of ≥ 0.15 μg/L (high) compared with less than 0.15 μg/L (normal). (B) Recurrence-free survival for E1694 patients (n = 667) with baseline S100B level of ≥ 0.15 μg/L (high) compared with less than 0.15 μg/L (normal).